Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation.
Velardi
Andrea
A
Division of Hematology and Clinical Immunology, Perugia, Italy.
Ruggeri
Loredana
L
Capanni
Marusca
M
Mancusi
Antonella
A
Perruccio
Katia
K
Aversa
Franco
F
Martelli
Massimo Fabrizio
MF
D000818:Animals; D003602:Cytotoxicity, Immunologic; D006086:Graft vs Host Disease / Q000209:etiology / Q000517:prevention & control; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology*; D006239:Haplotypes / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006648:Histocompatibility; D006801:Humans; D016219:Immunotherapy, Adoptive; D007519:Isoantigens / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology / Q000637:transplantation*; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D011828:Radiation Chimera; D011971:Receptors, Immunologic / Q000235:genetics / Q000276:immunology; D054340:Receptors, KIR; D014019:Tissue Donors; D016896:Treatment Outcome
D006680:HLA Antigens; D007519:Isoantigens; D011971:Receptors, Immunologic; D054340:Receptors, KIR